Literature DB >> 30526862

Variants in PUS7 Cause Intellectual Disability with Speech Delay, Microcephaly, Short Stature, and Aggressive Behavior.

Arjan P M de Brouwer1, Rami Abou Jamra2, Nadine Körtel3, Clara Soyris4, Daniel L Polla5, Modi Safra4, Avia Zisso4, Christopher A Powell6, Pedro Rebelo-Guiomar6, Nadja Dinges3, Violeta Morin3, Michael Stock3, Mureed Hussain7, Mohsin Shahzad8, Saima Riazuddin9, Zubair M Ahmed9, Rolph Pfundt10, Franziska Schwarz10, Lonneke de Boer11, André Reis12, Detilina Grozeva13, F Lucy Raymond13, Sheikh Riazuddin14, David A Koolen10, Michal Minczuk6, Jean-Yves Roignant3, Hans van Bokhoven10, Schraga Schwartz15.   

Abstract

We describe six persons from three families with three homozygous protein truncating variants in PUS7: c.89_90del (p.Thr30Lysfs∗20), c.1348C>T (p.Arg450∗), and a deletion of the penultimate exon 15. All these individuals have intellectual disability with speech delay, short stature, microcephaly, and aggressive behavior. PUS7 encodes the RNA-independent pseudouridylate synthase 7. Pseudouridylation is the most abundant post-transcriptional modification in RNA, which is primarily thought to stabilize secondary structures of RNA. We show that the disease-related variants lead to abolishment of PUS7 activity on both tRNA and mRNA substrates. Moreover, pus7 knockout in Drosophila melanogaster results in a number of behavioral defects, including increased activity, disorientation, and aggressiveness supporting that neurological defects are caused by PUS7 variants. Our findings demonstrate that RNA pseudouridylation by PUS7 is essential for proper neuronal development and function.
Copyright © 2018 American Society of Human Genetics. All rights reserved.

Entities:  

Keywords:  Drosophila melanogaster; aggressive behavior; growth delay; intellectual disability; mRNA substrates; microcephaly; neurodevelopmental delay; pseudouridylation; speech delay; tRNA

Mesh:

Substances:

Year:  2018        PMID: 30526862      PMCID: PMC6288278          DOI: 10.1016/j.ajhg.2018.10.026

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  No-bridge of Drosophila melanogaster: portrait of a structural brain mutant of the central complex.

Authors:  R Strauss; U Hanesch; M Kinkelin; R Wolf; M Heisenberg
Journal:  J Neurogenet       Date:  1992-09       Impact factor: 1.250

2.  Posttranscriptionally modified nucleosides in transfer RNA: their locations and frequencies.

Authors:  H Grosjean; M Sprinzl; S Steinberg
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

3.  Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome.

Authors:  Xiaoyu Li; Ping Zhu; Shiqing Ma; Jinghui Song; Jinyi Bai; Fangfang Sun; Chengqi Yi
Journal:  Nat Chem Biol       Date:  2015-06-15       Impact factor: 15.040

Review 4.  Pseudouridines in spliceosomal snRNAs.

Authors:  Andrew T Yu; Junhui Ge; Yi-Tao Yu
Journal:  Protein Cell       Date:  2011-10-06       Impact factor: 14.870

5.  Effects of nucleotide substitution and modification on the stability and structure of helix 69 from 28S rRNA.

Authors:  Minako Sumita; Jean-Paul Desaulniers; Yu-Cheng Chang; Helen M-P Chui; Lawrence Clos; Christine S Chow
Journal:  RNA       Date:  2005-09       Impact factor: 4.942

Review 6.  Pseudouridine: still mysterious, but never a fake (uridine)!

Authors:  Felix Spenkuch; Yuri Motorin; Mark Helm
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

7.  Investigation of Overhauser effects between pseudouridine and water protons in RNA helices.

Authors:  Meredith I Newby; Nancy L Greenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

8.  The yeast tRNA:pseudouridine synthase Pus1p displays a multisite substrate specificity.

Authors:  Y Motorin; G Keith; C Simon; D Foiret; G Simos; E Hurt; H Grosjean
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

9.  TRUB1 is the predominant pseudouridine synthase acting on mammalian mRNA via a predictable and conserved code.

Authors:  Modi Safra; Ronit Nir; Daneyal Farouq; Ilya Vainberg Slutskin; Schraga Schwartz
Journal:  Genome Res       Date:  2017-01-10       Impact factor: 9.043

10.  Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations.

Authors:  Michelangelo Cao; Marta Donà; M Lucia Valentino; Lucia Valentino; Claudio Semplicini; Alessandra Maresca; Matteo Cassina; Alessandra Torraco; Eva Galletta; Valeria Manfioli; Gianni Sorarù; Valerio Carelli; Roberto Stramare; Enrico Bertini; Rosalba Carrozzo; Leonardo Salviati; Elena Pegoraro
Journal:  Neurogenetics       Date:  2015-11-10       Impact factor: 2.660

View more
  34 in total

1.  Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.

Authors:  Eszter Balogh; Jennifer C Chandler; Máté Varga; Mona Tahoun; Dóra K Menyhárd; Gusztáv Schay; Tomas Goncalves; Renáta Hamar; Regina Légrádi; Ákos Szekeres; Olivier Gribouval; Robert Kleta; Horia Stanescu; Detlef Bockenhauer; Andrea Kerti; Hywel Williams; Veronica Kinsler; Wei-Li Di; David Curtis; Maria Kolatsi-Joannou; Hafsa Hammid; Anna Szőcs; Kristóf Perczel; Erika Maka; Gergely Toldi; Florentina Sava; Christelle Arrondel; Magdolna Kardos; Attila Fintha; Ahmed Hossain; Felipe D'Arco; Mario Kaliakatsos; Jutta Koeglmeier; William Mifsud; Mariya Moosajee; Ana Faro; Eszter Jávorszky; Gábor Rudas; Marwa H Saied; Salah Marzouk; Kata Kelen; Judit Götze; George Reusz; Tivadar Tulassay; François Dragon; Géraldine Mollet; Susanne Motameny; Holger Thiele; Guillaume Dorval; Peter Nürnberg; András Perczel; Attila J Szabó; David A Long; Kazunori Tomita; Corinne Antignac; Aoife M Waters; Kálmán Tory
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

2.  PUS7 mutations impair pseudouridylation in humans and cause intellectual disability and microcephaly.

Authors:  Ranad Shaheen; Monika Tasak; Sateesh Maddirevula; Ghada M H Abdel-Salam; Inas S M Sayed; Anas M Alazami; Tarfa Al-Sheddi; Eman Alobeid; Eric M Phizicky; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2019-02-18       Impact factor: 4.132

3.  Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation.

Authors:  Jinghui Song; Yuan Zhuang; Chenxu Zhu; Haowei Meng; Bo Lu; Bingteng Xie; Jinying Peng; Mo Li; Chengqi Yi
Journal:  Nat Chem Biol       Date:  2019-12-09       Impact factor: 15.040

4.  Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique.

Authors:  Cecilia Martinez Campos; Kevin Tsai; David G Courtney; Hal P Bogerd; Christopher L Holley; Bryan R Cullen
Journal:  RNA       Date:  2021-08-10       Impact factor: 4.942

Review 5.  The tRNA regulome in neurodevelopmental and neuropsychiatric disease.

Authors:  Jennifer Blaze; Schahram Akbarian
Journal:  Mol Psychiatry       Date:  2022-05-03       Impact factor: 15.992

Review 6.  Epitranscriptomic dynamics in brain development and disease.

Authors:  Andrew M Shafik; Emily G Allen; Peng Jin
Journal:  Mol Psychiatry       Date:  2022-04-26       Impact factor: 15.992

Review 7.  Regulation and Function of RNA Pseudouridylation in Human Cells.

Authors:  Erin K Borchardt; Nicole M Martinez; Wendy V Gilbert
Journal:  Annu Rev Genet       Date:  2020-09-01       Impact factor: 16.830

8.  An intellectual disability-associated missense variant in TRMT1 impairs tRNA modification and reconstitution of enzymatic activity.

Authors:  Kejia Zhang; Jenna M Lentini; Christopher T Prevost; Mais O Hashem; Fowzan S Alkuraya; Dragony Fu
Journal:  Hum Mutat       Date:  2020-01-16       Impact factor: 4.878

Review 9.  The expanding world of tRNA modifications and their disease relevance.

Authors:  Tsutomu Suzuki
Journal:  Nat Rev Mol Cell Biol       Date:  2021-03-03       Impact factor: 94.444

10.  HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.

Authors:  Dan Song; Ming Guo; Shuai Xu; Xiaotian Song; Bin Bai; Zhengyan Li; Jie Chen; Yanxin An; Yongzhan Nie; Kaichun Wu; Shiqi Wang; Qingchuan Zhao
Journal:  J Exp Clin Cancer Res       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.